when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

8,127 products tracked

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health

Human Epidermal Growth Factor Receptor 2 Low Breast Cancer (HER2 Low Breast C…

Sodium channel protein type 9 subunit alpha

Seasonal Influenza

Influenza A Virus, H5N1 Subtype Infections

page 101 of 271

131

Phase 1

GT-01

Obesity

Gila Therapeutics Inc

0 catalysts

Myelodysplastic Syndrome (Preleukemia)

$GTBPGT Biopharma, Inc.

Epithelial Ovarian Cancer

$GTBPGT Biopharma, Inc.

Alzheimer's Disease

Gismo Therapeutics Inc

GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE

GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE (GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE)

GUANFACINE (GUANFACINE)

Cervical Cancer

GV20 Therapeutics LLC

Unspecified Cancer

Groovy Medicine Inc

Lafora Disease (Unverricht Disease)

Pulmonary Arterial Hypertension

Gallium Maltolate

Recurrent Glioblastoma Multiforme (GBM)

$KMCMTitan Holdings Corp.

Famotidine (famotidine)

Corrosive Esophagitis (Erosive Esophagitis)

Sagent Pharmaceuticals Inc

Gene Therapies to Activate NAGLU for Mucopolysaccharidosis Type IIIB

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )

Gene Therapy Product

Chemotherapy Induced Peripheral Neuropathy

Navega Therapeutics Inc

Gene Therapy for Alpha-Mannosidosis

Alpha-Mannosidosis

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Gene Therapy for Arginase 1 Deficiency

Hyperargininemia (Arginase I Deficiency)

UCLA Health System

Gene Therapy for Bone Fracture

Cedars-Sinai Medical Center

Gene Therapy for Branched-Chain 2-Ketoacid Dehydrogenase Deficiency

Maple Syrup Urine Disease

Clinic for Special Children

Gene Therapy for Limb-Girdle Muscular Dystrophy Type 2C/R5

Limb-Girdle Muscular Dystrophy

Evolyra Therapeutics

Gene Therapy to Activate Artemis for Severe Combined Immune Deficiency

Severe Combined Immune Deficiency (SCID)

University of California San Francisco

Gene Therapy to Activate CD40LG for Genetic Disorders

University of California Los Angeles

Gene Therapy to Activate FOXP3 for Immune Dysregulation Polyendocrinopathy X-linked (IPEX) Syndrome

Gene Therapy to Activate IL-2 Gamma Receptor for SCID-X1

Boston Children's Hospital

Gene Therapy to Activate PCCA for Propionic Acidemia

Propionic Acidemia

National Institutes of Health

Gene Therapy to Activate Retinoschisin for X-Linked Retinoschisis

Retinal Degeneration

National Eye Institute

Gene Therapy to Activate gp91phox for Chronic Granulomatous Disease

Chronic Granulomatous Disease

Gene Therapy to Target BCMA and CS1 for Multiple Myeloma

Multiple Myeloma (Kahler Disease)

University of California Los Angeles